Get 20% Free Customization In This Report

Buy this report from - $4176

Orthopedic Implants Market by Product [Reconstructive Joint Replacements {Knee Replacement Implants, Hip Replacement Implants, and Extremities}, Spinal Implants {Spinal Fusion Devices, Non-Fusion Devices/Motion Preservation Devices, and Invasive Spinal Bone Stimulators}, Dental Implants {Root Form and Plate Form Dental Implants}, Trauma & Craniomaxillofacial {Screws, Plates, Staples, and Others}, Orthobiologics {Allografts, Bone Graft Substitutes, and Cell-Based Matrices}, and Others] and Biomaterials [Metallic, Ceramics, Polymers, and Natural] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Medical Devices & Supplies	LI_172175	Pages: 210	Apr 2017 \| 4576 Views
Author's : Garima Chandra and Divya Srivastava	Tables: 85	Charts: 58	Formats*:

Orthopedic Implants Market Overview:

Global Orthopedic Implants Market was valued at $47,261 million in 2016, and is expected to garner $74,796 million by 2023, registering a CAGR of 6.8% during the forecast period 2017 - 2023. Orthopedic implants are manufactured to replace or support a missing or damaged bone or joint. These implants are intended to treat the deformities, stabilize body posture, and restore the normal skeletal function. The orthopedic implants market has witnessed a shift from conventional surgical procedures to the use of modern fixation and prosthetic devices. The demand for orthopedic implants has increased significantly, owing to rise in geriatric population that increases the risk of osteoporosis, osteoarthritis, technological innovations in the orthopedic implants, and other musculoskeletal disorders.

Get more information on this report : Request Sample Pages

The global orthopedic implants market is segmented based on product, biomaterial, and geography. Based on product, it is classified into reconstructive joint replacements, spinal implants, dental implants, trauma & craniomaxillofacial, orthobiologics, and others. The reconstructive joint replacements market is further divided into knee, hip, and extremities. Spinal implants are further categorized into spinal fusion devices, non-fusion devices/motion preservation devices, and invasive spinal bone stimulators. Dental implants are further bifurcated into root form dental implants and plate form dental implants. Trauma & Craniomaxillofacial are further categorized into screws, plates, staples, and others. Orthobiologics are further classified into allografts, bone graft substitutes, and cell-based matrices. Based on biomaterials, it is categorized into metallic, ceramic, polymeric, and natural biomaterials. Among biomaterials, the metallic segment occupied dominant share in 2016, and is expected to maintain this trend during the forecast period, owing to their exclusive load bearing properties.

Drivers, Restraints, and Opportunities

The impact of the driving factors is expected to surpass the effect of restraints. Moreover, increase in R&D in orthopedic implants and the untapped emerging economies are expected to provide new market opportunities to orthopedic implants manufacturers in the near future.

Global Orthopedic Implants Market Key Product Segment

The metallic biomaterial segment accounted for a significant share in the global orthopedic implants market, and this trend is expected to continue during the forecast period.

LAMEA Orthopedic Implants Market

Rise in incidence of orthopedic disease and rapid adoption of orthopedic implants for its treatment drive the growth of the orthopedic implants market in LAMEA. However, the countries in Latin America have low gross income, thereby lowering expenditures on the development of new methods and devices for the treatment of orthopedic disease. Lack of healthcare facilities and increased need for treatment devices for orthopedic disease have increased the penetration of major players in the Middle East. Nevertheless, the market growth is driven by improvement in healthcare infrastructure and rise in disposable income. Middle East is expected to exhibit the highest CAGR of 8.3% from 2017 to 2023.

The key players operating in the global orthopedic implants market include Zimmer Biomet Holdings, Inc., Medtronic plc., Stryker Corporation, Johnson & Johnson (DePuy Synthes), The Orthopedic Implant Company, Smith and Nephew plc., Wright Medical Group N.V., BioTek Instruments, Inc., Aesculap Implant Systems, and Conmed Corporation.

The other prominent players in the value chain include Arthrex, Inc., NuVasive, Inc., Globus Medical, Inc., Integra Lifesciences Holdings Corporation, Synthes Holding AG, Arthrocare Corporation, and Baxter International Inc.

Key Benefits for Stakeholders

The study provides an in-depth analysis of the global orthopedic implants market, with current trends and future estimations to elucidate the imminent investment pockets.
A quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities is discussed.
Key market players are profiled and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the market.
Porters Five Forces model is expected to interpret the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

Orthopedic Implants Market Key Segments:

By Product

Reconstructive Joint Replacements
- Knee Replacement Implants
- Hip Replacement Implants
- Extremities
  - Upper Extremity Reconstruction
    - Shoulder Implants
    - Elbow Implants
    - Hand Wrist Implants
  - Lower Extremity Reconstruction
    - Foot Implants
    - Ankle Implants
Spinal Implants
- Spinal Fusion Devices
  - Thoracolumbar Devices
  - Cervical Fixation Devices
  - Interbody Fusion Devices
- Non-fusion Devices/Motion Preservation Devices
  - Balloon Kyphoplasty Devices
  - Vertebroplasty Devices
- Invasive Spinal Bone Stimulators
Dental Implants
- Root Form Dental Implants
- Plate Form Dental Implants
Trauma & Craniomaxillofacial
- Screws
- Plates
- Staples
- Others
Orthobiologics
- Allografts
  - Machined Allografts
  - Demineralised Bone Matrix
- Bone Graft Substitutes
  - Bone Morphogenic Proteins (BMP)
  - Synthetic Bone Grafts
- Cell based Matrices
Others

By Biomaterial

Metallic Biomaterials
Polymeric Biomaterials
Ceramic Biomaterials
Natural Biomaterials

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY

1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Market share analysis, 2016

3.3. PORTER’S FIVE FORCES ANALYSIS

3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry

3.4. CLINICAL TRIALS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rise in incidence of orthopedic diseases coupled with growing ageing population
3.5.1.2. Technological advancements in the field of orthopedic implants
3.5.1.3. Global rise in acceptance of orthopedic implants
3.5.1.4. Improved healthcare facilities in developing countries

3.5.2. Restraints

3.5.2.1. High cost of treatment associated with orthopedic implants procedures
3.5.2.2. Stringent approval process as these are highly specialized devices

3.5.3. Opportunities

3.5.3.1. Huge market opportunities in the developing countries

Chapter: 4 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. RECONSTRUCTIVE JOINT REPLACEMENTS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Knee replacement implants

4.2.4.1. Market size and forecast

4.2.5. Hip replacement implants

4.2.5.1. Market size and forecast

4.2.6. Extremities

4.2.6.1. Market size and forecast
4.2.6.2. Upper extremity reconstruction

4.2.6.2.1. Market size and forecast
4.2.6.2.2. Shoulder reconstruction

4.2.6.2.2.1. Market size and forecast

4.2.6.2.3. Elbow reconstruction

4.2.6.2.3.1. Market size and forecast

4.2.6.2.4. Hand & wrist

4.2.6.2.4.1. Market size and forecast

4.2.6.3. Lower extremity reconstruction

4.2.6.3.1. Market size and forecast
4.2.6.3.2. Foot reconstruction

4.2.6.3.2.1. Market size and forecast

4.2.6.3.3. Ankle reconstruction

4.2.6.3.3.1. Market size and forecast

4.3. SPINAL IMPLANTS

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Spinal fusion devices

4.3.4.1. Market size and forecast
4.3.4.2. Thoracolumbar devices

4.3.4.2.1. Market size and forecast

4.3.4.3. Cervical fixation devices

4.3.4.3.1. Market size and forecast

4.3.4.4. Interbody fusion devices

4.3.4.4.1. Market size and forecast

4.3.5. Motion preservation devices

4.3.5.1. Market size and forecast
4.3.5.2. Dynamic stabilization devices

4.3.5.2.1. Market size and forecast

4.3.5.3. Artificial discs

4.3.5.3.1. Market size and forecast

4.3.5.4. Annulus repair devices

4.3.5.4.1. Market size and forecast

4.3.5.5. Nuclear disc prostheses

4.3.5.5.1. Market size and forecast

4.3.6. Vertebral compression fracture (vcf) treatment devices

4.3.6.1. Market size and forecast
4.3.6.2. Balloon kyphoplasty devices

4.3.6.2.1. Market size and forecast

4.3.6.3. Vertebroplasty devices

4.3.6.3.1. Market size and forecast

4.3.7. Invasive spinal bone stimulators

4.3.7.1. Market size and forecast

4.4. DENTAL IMPLANTS

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Root form dental implants

4.4.4.1. Market size and forecast

4.4.5. Plate form dental implants

4.4.5.1. Market size and forecast

4.5. ORTHOBIOLOGICS

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Allografts

4.5.4.1. Market size and forecast
4.5.4.2. Machined allograft

4.5.4.2.1. Market size and forecast

4.5.4.3. Demineralized bone matrix (dbm)

4.5.4.3.1. Market size and forecast

4.5.5. Bone graft substitutes

4.5.5.1. Market size and forecast
4.5.5.2. Bone morphogenic proteins (bmp)

4.5.5.2.1. Market size and forecast

4.5.5.3. Synthetic bone grafts

4.5.5.3.1. Market size and forecast

4.5.6. Cell based matrices (cbm)

4.5.6.1. Market size and forecast

4.6. TRAUMA & CRANIOMAXILLOFACIAL

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Screw

4.6.4.1. Market size and forecast

4.6.5. Plates

4.6.5.1. Market size and forecast

4.6.6. Staples

4.6.6.1. Market size and forecast

4.6.7. Others

4.6.7.1. Market size and forecast

4.7. OTHERS

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

Chapter: 5 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CERAMICS BIOMATERIALS

5.2.1. Market size and forecast

5.3. METALLIC BIOMATERIALS

5.3.1. Market size and forecast

5.4. POLYMERIC BIOMATERIALS

5.4.1. Market size and forecast

5.5. NATURAL BIOMATERIALS

5.5.1. Market size and forecast

Chapter: 6 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast by country
6.2.4. Market size and forecast by Product
6.2.5. Market size and forecast by Biomaterial

6.2.5.1. U.S. market size and forecast
6.2.5.2. Canada market size and forecast
6.2.5.3. Mexico market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast by country
6.3.4. Market size and forecast by Product
6.3.5. Market size and forecast by Biomaterial

6.3.5.1. Germany market size and forecast
6.3.5.2. France market size and forecast
6.3.5.3. UK market size and forecast
6.3.5.4. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast by country
6.4.4. Market size and forecast by Product
6.4.5. Market size and forecast by Biomaterial

6.4.5.1. Japan market size and forecast
6.4.5.2. China market size and forecast
6.4.5.3. India market size and forecast
6.4.5.4. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast by country
6.5.4. Market size and forecast by Product
6.5.5. Market size and forecast by Biomaterial

6.5.5.1. Latin America market size and forecast
6.5.5.2. Africa market size and forecast
6.5.5.3. Middle East market size and forecast

Chapter: 7 COMPANY PROFILES

7.1. AESCULAP IMPLANT SYSTEMS

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Key strategic moves and developments

7.2. B. BRAUN MELSUNGEN AG (AESCULAP AG)

7.2.1. Company overview
7.2.2. Company Snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments

7.3. BIOTRONIK SE & CO. KG

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Key strategic moves and developments

7.4. CONMED CORPORATION

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. GLOBUS MEDICAL, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating product categories
7.5.4. Business performance
7.5.5. Key strategic moves and developments, 2014-2016

7.6. JOHNSON & JOHNSON

7.6.1. Company overview
7.6.2. Company Snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments

7.7. MEDTRONIC PLC

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. SMITH & NEPHEW PLC.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. STRYKER CORPORATION

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.9.7. Operating Business Segments
7.9.8. Business performance
7.9.9. Key strategic moves and developments

7.10. ZIMMER BIOMET HOLDINGS, INC.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating product categories
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL RECONSTRUCTIVE JOINT REPLACEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. KNEE REPLACEMENT IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. HIP REPLACEMENT IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 6. GLOBAL UPPER EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 7. SHOULDER RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. ELBOW RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. HAND & WRIST RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL LOWER EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 11. FOOT RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. ANKLE RECONSTRUCTION MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13. PRODUCT ANALYSIS: SPINAL IMPLANTS
TABLE 14. GLOBAL SPINAL IMPALNTS ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 15. GLOBAL SPINAL FUSION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 16. THORACOLUMBAR DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. CERVICAL FIXATION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18. INTERBODY FUSION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19. GLOBAL MOTION PRESERVATION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 20. DYNAMIC STABILIZATION DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21. ARTIFICIAL DISCS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22. ANNULUS REPAIR DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23. NUCLEAR DISC PROSTHESES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24. GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 25. BALLOON KYPHOPLASTY DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 26. VERTEBROPLASTY DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 27. INVASIVE SPINAL BONE STIMULATORS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 28. GLOBAL DENTAL IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 29. ROOT-FORM DENTAL IMPLANT MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 30. PLATE-FORM DENTAL IMPLANT MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 31. GLOBAL ORTHOBIOLOGICS IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 32. GLOBAL ALLOGRAFT IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 33. MACHINED ALLOGRAFTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 34. DEMINERALIZED BONE MATRIX MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 35. GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 36. BONE MORPHOGENETIC PROTEIN MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 37. SYNTHETIC BONE GRAFTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 38. CELL BASED MATRICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 39. GLOBAL TRAUMA AND CRANIOMAXILLOFACIAL MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 40. DIFFERENT TYPES OF BONE SCREWS AND THEIR APPLICATION
TABLE 41. TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR SCREW, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 42. TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR PLATES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 43. TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR STAPLES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 44. OTHER TRAUMA AND CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 45. OTHER ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 46. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 47. CERAMICS BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 48. METALLIC BIOMATERIALS AND THEIR APPLICATIONS
TABLE 49. METALLIC BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 50. POLYMERIC BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 51. NATURAL BIOMATERIALS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 52. ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 53. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 54. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 55. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 56. RHEUMATOID ARTHRITIS CASES IN THE UK EACH YEAR
TABLE 57. EUROPE ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 58. EUROPE ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 59. EUROPE ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 60. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 61. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 62. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 63. LAMEA ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 64. LAMEA ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 65. LAMEA ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)
TABLE 66. AESCULAP: COMPANY SNAPSHOT
TABLE 67. AESCULAP: PRODUCT PORTFOLIO
TABLE 68. B. BRAUN: COMPANY SNAPSHOT
TABLE 69. B. BRAUN: OPERATING SEGMENTS
TABLE 70. BIOTRONIK: COMPANY SNAPSHOT
TABLE 71. BIOTRONIK: OPERATING SEGMENTS
TABLE 72. BIOTRONIK: PRODUCT PORTFOLIO
TABLE 73. CONMED: COMPANY SNAPSHOT
TABLE 74. CONMED: OPERATING SEGMENTS
TABLE 75. CONMED: PRODUCT PORTFOLIO
TABLE 76. GLOBUS MEDICAL: COMPANY SNAPSHOT
TABLE 77. GLOBUS MEDICAL: PRODUCT CATEGORIES
TABLE 78. J&J: COMPANY SNAPSHOT
TABLE 79. J&J: OPERATING SEGMENTS
TABLE 80. J&J: PRODUCT PORTFOLIO
TABLE 81. MEDTRONIC: COMPANY SNAPSHOT
TABLE 82. MEDTRONIC: OPERATING SEGMENTS
TABLE 83. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 84. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 85. SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 86. STRYKER: COMPANY SNAPSHOT
TABLE 87. STRYKER: OPERATING SEGMENTS
TABLE 88. STRYKER: PRODUCT PORTFOLIO
TABLE 89. WRIGHT MEDICAL: COMPANY SNAPSHOT
TABLE 90. WRIGHT MEDICAL: OPERATING SEGMENTS
TABLE 91. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 92. ZIMMER BIOMET: PRODUCT CATEGORIES
TABLE 93. ZIMMER BIOMET: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. GLOBAL SNAPSHOT OF ORTHOPEDIC IMPLANTS MARKET, 2016-2023
FIGURE 2. SNAPSHOT OF ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023
FIGURE 3. GLOBAL ORTHOPEDIC IMPLANTS MARKET SEGMENTATION
FIGURE 4. TOP INVESTMENT POCKETS IN GLOBAL ORTHOPEDIC IMPLANTS MARKET
FIGURE 5. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2016
FIGURE 6. TOTAL NUMBER OF STRATEGIES
FIGURE 7. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 8. MARKET SHARE ANALYSIS: ORTHOPEDIC IMPLANTS MARKET, 2016
FIGURE 9. BARGAINING POWER OF BUYERS, 2016
FIGURE 10. BARGAINING POWER OF SUPPLIERS, 2016
FIGURE 11. THREAT OF SUBSTITUTES, 2016
FIGURE 12. THREAT OF NEW ENTRANTS, 2016
FIGURE 13. COMPETITIVE RIVALRY, 2016
FIGURE 14. CLINICAL TRIALS FOR ORTHOPEDIC IMPLANTS (%)
FIGURE 15. ORTHOPEDIC IMPLANTS: MARKET DYNAMICS
FIGURE 16. GLOBAL ORTHOPEDIC IMPLANT MARKET: IMPACT ANALYSIS
FIGURE 17. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY TYPE
FIGURE 18. U.S. ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 19. CANADA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 20. MEXICO ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 21. GERMANY ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 22. FRANCE ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 23. UK ORTHOPEDIC IMPLANTS DMARKET, 2016-2023 ($MILLION)
FIGURE 24. REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 25. JAPAN ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 26. CHINA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 27. INDIA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 28. REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 29. LATIN AMERICA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 30. SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 31. MIDDLE EAST ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)
FIGURE 32. B. BRAUN: NET SALES, 2014-2016 ($MILLION)
FIGURE 33. B. BRAUN: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 34. B. BRAUN: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 35. CONMED: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. CONMED: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 37. CONMED: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 38. GLOBUS MEDICAL: REVENUE, 2014-2016 ($MILLION)
FIGURE 39. GLOBUS MEDICAL: REVENUE BY REGION, 2016 (%)
FIGURE 40. GLOBUS MEDICAL: REVENUE BY PRODUCT, 2016 (%)
FIGURE 41. J&J: NET SALES, 2014-2016 ($MILLION)
FIGURE 42. J&J: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 43. J&J: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 44. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 45. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 46. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 47. SMITH & NEPHEW: NET SALES, 2014-2016 ($MILLION)
FIGURE 48. SMITH & NEPHEW: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 49. SMITH & NEPHEW: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 50. STRYKER: NET SALES, 2014-2016 ($MILLION)
FIGURE 51. STRYKER: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 52. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 53. WRIGHT MEDICAL: NET SALES, 2014-2016 ($MILLION)
FIGURE 54. WRIGHT MEDICAL: REVENUE SHARE, BY PRODUCT, 2016 (%)
FIGURE 55. WRIGHT MEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2016 (%)
FIGURE 56. ZIMMER BIOMET: NET SALES, 2014-2016 ($MILLION)
FIGURE 57. ZIMMER BIOMET: REVENUE SHARE BY SEGMENTS, 2016 (%)
FIGURE 58. ZIMMER BIOMET: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

The adoption of orthopedic implants, such as orthobiologics, hip, and knee replacements implants, is expected to increase in the near future, owing to high prevalence of orthopedic diseases, such as arthritis and osteoporosis, and rise in geriatric population. The orthopedic implants market has gained the interest of healthcare providers due to the benefits offered in the effective treatment of orthopedic diseases. Significant technological advancements in orthopedic implants have had a significant impact on orthopedic disease treatment. Currently, joint replacement and reconstruction procedures are widely adopted in clinical practice, owing to their benefits, such as improved patient outcomes and pain relief. Asia-Pacific and LAMEA are expected to offer lucrative opportunities to market players, as the markets in developed nations are saturated with large number of orthopedic implants.

The global market is driven by emergence of new trends in the orthopedic implants industry, growth in incidence of chronic orthopedic diseases, rapid surge in aging population, technological advancements, rise in acceptance of orthopedic implants, and improvement of healthcare infrastructure in the emerging nations. However, this growth is restricted by high cost of these implants (especially in the developing nations) and stringent regulatory policies for their approval. Conversely, the emerging markets of the Asia-Pacific and LAMEA are expected to provide several growth opportunities during the forecast period.

According to the corporate executives, the increase in obesity and rise in osteoporosis-related fracture among in U.S. all age groups are expected to maintain the demand for orthopedic interventions. In addition, the emerging markets have gained more importance for the majority of the orthopedic implant manufacturers and distributors. A rapid growth was observed in the shipments of these implants during the study period to provide improved healthcare services in the emerging nations, and is expected to offset the challenging conditions in mature markets, such as North America and Europe. In addition, North America is expected to dominate the global orthopedic implants market during the forecast period, followed by Europe.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Orthopedic Implants Market Overview: